ES8604097A1 - Procedimiento para preparar derivados del acido benzoico - Google Patents

Procedimiento para preparar derivados del acido benzoico

Info

Publication number
ES8604097A1
ES8604097A1 ES544741A ES544741A ES8604097A1 ES 8604097 A1 ES8604097 A1 ES 8604097A1 ES 544741 A ES544741 A ES 544741A ES 544741 A ES544741 A ES 544741A ES 8604097 A1 ES8604097 A1 ES 8604097A1
Authority
ES
Spain
Prior art keywords
protease inhibitors
degradation
preventing
elastin
retarding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544741A
Other languages
English (en)
Other versions
ES544741A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES544741A0 publication Critical patent/ES544741A0/es
Publication of ES8604097A1 publication Critical patent/ES8604097A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DEL ACIDO BENZOICO. COMPRENDE: A) DESHIDRATAR A LOS ALCOHOLES DE FORMULA (II), EN REFLUJO DE BENCENO O TOLUENO CONTENIENDO P-TOLUENSULFONICO, PARA OBTENER UN ALQUENOL DE FORMULA (III); Y B) HIDROGENAR A (III), EN UN DISOLVENTE COMO ACIDO ACETICO Y EN PRESENCIA DE UN CATALIZADOR COMO PD O RD, PARA OBTENER UN COMPUESTO DE FORMULA (I), Y SUS SALES DE ADICION FARMACOLOGICAMENTE ACEPTABLES. SIENDO: R1 Y R2, H O ALQUILO DE C 1 A 6; R3 -CH2R4 Y R4 ALQUILO DE C 13 A 25. SE UTILIZA PARA REDUCIR LA DEGRADACION DE TEJIDOS NATURALES EN MAMIFEROS.
ES544741A 1983-05-09 1985-07-01 Procedimiento para preparar derivados del acido benzoico Expired ES8604097A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/492,842 US4499295A (en) 1983-05-09 1983-05-09 Protease inhibitors

Publications (2)

Publication Number Publication Date
ES544741A0 ES544741A0 (es) 1986-01-16
ES8604097A1 true ES8604097A1 (es) 1986-01-16

Family

ID=23957846

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532342A Expired ES8606241A1 (es) 1983-05-09 1984-05-09 Procedimiento para preparar derivados del acido benzoico.
ES544741A Expired ES8604097A1 (es) 1983-05-09 1985-07-01 Procedimiento para preparar derivados del acido benzoico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES532342A Expired ES8606241A1 (es) 1983-05-09 1984-05-09 Procedimiento para preparar derivados del acido benzoico.

Country Status (8)

Country Link
US (1) US4499295A (es)
EP (1) EP0124905B1 (es)
JP (1) JPS59206332A (es)
AU (1) AU581405B2 (es)
CA (1) CA1261868A (es)
DE (1) DE3461077D1 (es)
ES (2) ES8606241A1 (es)
ZA (1) ZA843450B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
DE3515278A1 (de) * 1985-04-27 1986-10-30 Grünenthal GmbH, 5190 Stolberg Neue benzoesaeurederivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
DE3518655A1 (de) * 1985-05-24 1986-11-27 Grünenthal GmbH, 5190 Stolberg Neue phenolderivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
FR2607498B1 (fr) * 1986-12-01 1991-04-05 Oreal Nouveaux salicylates lipophiles d'ammoniums quaternaires, leur utilisation en cosmetique et en dermopharmacie
US4803294A (en) * 1987-10-29 1989-02-07 G. D. Searle & Co. Process and intermediates for the preparation of halogenated protease inhibitors
LU87408A1 (fr) * 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
US5262407A (en) * 1988-12-16 1993-11-16 L'oreal Use of salicylic derivatives for the treatment of skin aging
US5086067A (en) * 1989-12-18 1992-02-04 G. D. Searle & Co. Ltb4 synthesis inhibitors
US5112864A (en) * 1991-05-30 1992-05-12 G. D. Searle & Co. PLA2 inhibitors as antiinflammatories
FR2694934B1 (fr) * 1992-08-24 1994-11-10 Oreal Composition pour le traitement de l'acné contenant un dérivé d'acide salicylique et dérivés d'acide salicylique.
US5374772A (en) * 1992-12-08 1994-12-20 Hoffmann-Laroche Inc. Substituted benzoic acids, inhibitors of phospholipases A2
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
US6410777B1 (en) 1997-04-04 2002-06-25 Teijin Limited Salicylic acid ester derivative and its production
FR2780646B1 (fr) * 1998-07-06 2000-08-11 Oreal Composition cosmetique et/ou dermatologique contenant des derives d'acide salicylique et procede d'introduction des dits derives dans une composition aqueuse
US7384970B2 (en) * 2003-03-24 2008-06-10 Irm Llc Inhibitors of cathepsin S
US7109243B2 (en) * 2003-03-24 2006-09-19 Irm Llc Inhibitors of cathepsin S
US7173051B2 (en) * 2003-06-13 2007-02-06 Irm, Llc Inhibitors of cathepsin S
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
US20060177080A1 (en) * 2005-01-25 2006-08-10 Smith Richard C Earpiece with flanged extension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1184020A (en) * 1968-12-19 1970-03-11 Shell Int Research Salts of Polyvalent Metals and Alkylsalicylic Acids
BE757821A (fr) * 1970-08-01 1971-04-01 Recordati Chem Pharm Procede de preparation de l'acide 3-propionyl-salicylique et dederives de cet acide
EP0009699B1 (de) * 1978-09-30 1981-11-11 Bayer Ag Verfahren zur Herstellung weitgehend wasserfreier und Hydroxybenzoesäure-freier Alkalisalze von Hydroxybenzoesäureestern

Also Published As

Publication number Publication date
AU581405B2 (en) 1989-02-23
CA1261868A (en) 1989-09-26
EP0124905B1 (en) 1986-10-29
ES8606241A1 (es) 1986-04-01
US4499295A (en) 1985-02-12
EP0124905A1 (en) 1984-11-14
AU2778484A (en) 1984-11-15
DE3461077D1 (en) 1986-12-04
JPH0481578B2 (es) 1992-12-24
ZA843450B (en) 1985-06-26
ES532342A0 (es) 1986-04-01
ES544741A0 (es) 1986-01-16
JPS59206332A (ja) 1984-11-22

Similar Documents

Publication Publication Date Title
ES8606241A1 (es) Procedimiento para preparar derivados del acido benzoico.
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
DK0889875T3 (da) Cycloproylalkansyrederivater
DK0715623T3 (da) Blodpladeaggregationsinhibitorer
MY123908A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof
ATE20732T1 (de) Halogenierte proteaseinhibitoren.
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
DK0804418T3 (da) Platelataggregationshæmmere
ES2060417T3 (es) Procedimiento para la preparacion por compresion directa de comprimidos de derivados del acido cefalosporanico.
ES8606240A1 (es) Semiesteres pentanodioicos 3-sustituidos
GR79822B (es)
UA35554C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти у вигляді суміші ізомерів або окремих ізомерів, фармацевтична композиція, що має антибактеріальну активність та проміжні сполуки
ATE31925T1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide.
GB1495890A (en) Thioxanthenecarboxylic acid derivative
EP0091525A3 (en) Phosphonoalkanoylamino acids
CO4770982A1 (es) Nuevas formulaciones
SE8304972D0 (sv) Piperidinylcyklopentanolheptensyrasalt

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001